doi:10.2174/1381612826666200424180139 Park JM, Lee HJ, Sikiric P, Hahm KB
Mild to moderate pain Protocol: BPC-157: 250mcg twice daily Duration: 4-8 weeks Method: Injectable near pain site or systemic Expected outcome: 40-60% pain reduction Improved function May be sufficient alone Severe or chronic pain Protocol: BPC-157: 500mcg twice daily TB-500: 5-10mg weekly loading for 4-6 weeks, then 2-5mg maintenance Duration: 12-16 weeks minimum Method: Injectable Expected outcome: 50-70% pain reduction Significant functional improvement Better quality of life Multiple pain sites or systemic pain Protocol: BPC-157: 250-500mcg twice daily (systemic injections - abdomen/thighs) TB-500: 5mg weekly Optional: KPV 500mcg daily if inflammation major factor Duration: 12-24 weeks Expected outcome: 40-60% overall pain reduction Improved multiple areas Better mobility Maintenance protocol After initial relief: BPC-157: 250mcg daily OR every other day TB-500: 2-5mg weekly OR biweekly Duration: Ongoing as needed Why maintenance: Prevents pain return Continues healing Safe long-term Use our peptide dosing guide , peptide dosage chart , and how to calculate peptide dosages
Support mitochondrial function and cellular energy levels directly
These may include nausea, vomiting, severe motor control impairment, unconsciousness, and even a risk of alcohol poisoning
These peptides did sit in 503A Category 2 FDAs designation for substances that present significant safety risk and should not be compounded
268-270 Men with obstructive sleep apnea appear to have diminished erectile function, testosterone levels, and semen quality compared to men without sleep apnea
